×
ADVERTISEMENT

crizanlizumab

Experimental Antibody Reduces Sickle Cell–Related Pain Crises

Sickle cell disease is characterized by recurrent episodes of “sickle crisis,” in which a ...

FEBRUARY 6, 2017

Load more